Related Experiment Videos
Cardiovascular involvement in Kawasaki disease
S Noel Narayanan1, M Zulfikar Ahamed, M Safia
1Department of Pediatrics and Cardiology, SAT Hospital, Medical College, Thiruvananthapuram 695 011, India. noeln@asianetindia.com
Indian Pediatrics
|October 7, 2005
Summary
Early treatment with IV gammaglobulin for Kawasaki disease prevents coronary artery issues. Prompt treatment in children with Kawasaki disease significantly reduces the risk of developing long-term cardiac complications like coronary artery disease.
Area of Science:
- Pediatrics
- Cardiology
- Rheumatology
Background:
- Kawasaki disease is a significant cause of acquired heart disease in children.
- Cardiac involvement, including pancarditis and coronary artery abnormalities, is a major concern.
Purpose of the Study:
- To evaluate cardiac involvement in children with Kawasaki disease.
- To assess the long-term outcomes of coronary artery disease in affected children.
- To determine the efficacy of intravenous immunoglobulin (IVIG) in preventing cardiac complications.
Main Methods:
- Retrospective analysis of 72 patients diagnosed with Kawasaki disease over a 7-year period.
- Cardiac assessment including echocardiography to detect pancarditis and coronary artery abnormalities.
- Follow-up evaluation of coronary artery status and treatment outcomes.
Main Results:
- 28% of patients experienced mild pancarditis, which resolved.
- 18.5% developed coronary artery disease; 10 cases resolved within 1-2 years, while 3 had persistent dilatation/aneurysm.
- Children receiving IV gammaglobulin within 10 days of illness onset showed no coronary artery disease during follow-up.
Conclusions:
- Early administration of IV gammaglobulin is crucial for preventing coronary artery disease in Kawasaki disease.
- Prompt treatment significantly reduces the incidence and severity of cardiac complications.
- Long-term surveillance is important for children with persistent coronary artery abnormalities.